Beyond redox: vitamin C in signaling, epigenetic regulation and protein modification—relevance to cancer therapy

Amisha S Hebbar, Sandra Nixon, Hanumappa Ananda, Manasa Nune, Vinay Kumar Rao · 2026

Read Beyond redox: vitamin C in signaling, epigenetic regulation and protein modification—relevance to cancer therapy by Amisha S Hebbar, Sandra Nixon, Hanumappa Ananda, Manasa Nune, Vinay Kumar Rao (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13625384.txt.

Description

Hebbar and co-authors argue that vitamin C's reputation as a mere antioxidant undersells it badly, in this 2026 review. The vitamin is an essential helper for a family of enzymes. These enzymes chemically edit both DNA and histones, the spool proteins DNA wraps around. So vitamin C availability shapes which genes a cell can switch on. That carries consequences for stem cell identity and differentiation.

The review's most novel thread is a newly described direct modification. Vitamin C can attach itself to lysine building blocks inside proteins. The authors call the process vitcylation. It could rewrite protein behavior from within. These regulatory roles help explain the vitamin's context-dependent behavior in cancer, protective in some settings and fuel for tumors in others. The authors map what is known about signaling and epigenetic targets and call for systematic hunting of vitcylation targets to guide cancer therapy design.

Catalog record

CREATORAmisha S Hebbar, Sandra Nixon, Hanumappa Ananda, Manasa Nune, Vinay Kumar Rao
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE49 KB
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13625384

Browse the full library · About the Tower of Babel